EUVIMEDEUVIMED entdecken
Übersichtsarbeit

In Situ Peptide Assembly for Cancer Therapy

Guowei Liang iD, Xianbao Sun iD, Yu Ma, Tiantian Xia, Xiaotong Cheng, Gaolin Liang iD

Angewandte Chemie International Edition · 02.09.2026

DOI: 10.1002/anie.2719299 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 02.09.2026. Verfasst von Guowei Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Peptides, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 264 Literaturangaben. Gefördert von: Basic Research Program of Jiangsu, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptides have emerged as promising anticancer agents due to their biocompatibility and functional versatility, such as tumor targeting and cell penetrating capabilities. However, their clinical application is often limited by poor stability and rapid clearance. To overcome these drawbacks, peptide assembly strategies have been developed. Early approaches utilized preassembled peptide nanomaterials, but these approaches faced challenges in circulation and tumor penetration. Recently, in situ peptide assembly has gained increasing attention. This strategy involves administering molecular peptide‐drug precursors that undergo stimulus‐responsive activation in the tumor microenvironment to form nanostructures locally. This process utilizes an aggregation‐induced retention (AIR) effect for enhanced drug enrichment and retention at the tumor site. Furthermore, these in situ‐formed nanoassemblies can disrupt intracellular homeostasis and induce apoptosis, amplifying therapeutic outcomes. This review systematically elaborates on the mechanisms of in situ peptide assembly, classifies the diverse stimuli triggering this process, and comprehensively summarizes its applications in cancer therapy. Finally, current challenges and prospects in this advancing field are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesAntineoplastic AgentsNeoplasmsHumansNanostructuresAnimalsTumor MicroenvironmentApoptosis

Stichwörter der Autor:innen

aggregation‐induced retentioncancer therapyin situ assemblynanostructurepeptide

Substanzen

PeptidesAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
  • State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China.

ORCID-Profile: Guowei Liang, Xianbao Sun, Gaolin Liang

Förderung

  • Basic Research Program of Jiangsu
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Jiangsu Shuang Chuang Team
  • China Postdoctoral Science Foundation Funded Project
  • Postdoctoral Fellowship Program of CPSF
  • Jiangsu Funding Program for Excellent Postdoctoral Talent

Zitieren

APA

Liang, G., Sun, X., Ma, Y., Xia, T., Cheng, X., & Liang, G. (2026). In Situ Peptide Assembly for Cancer Therapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.2719299

Vancouver

Liang G, Sun X, Ma Y, Xia T, Cheng X, Liang G. In Situ Peptide Assembly for Cancer Therapy. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.2719299

BibTeX
@article{Liang2026,
  author = {Liang, Guowei and Sun, Xianbao and Ma, Yu and Xia, Tiantian and Cheng, Xiaotong and Liang, Gaolin},
  title = {In Situ Peptide Assembly for Cancer Therapy},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  doi = {10.1002/anie.2719299}
}
Kostenlos starten →